The support software DxCare prescription (7.7.2 version of 07.07.2015) certified type testing by the certification body SGS ICS meets the criteria in June 2012 of reference of the HAS. Coupled with Vidal Hoptimal database (version 2015.5.11 04/16/2015) DxCare has successfully passed the tests carried out during the audit dedicated. Security synonym, quality and traceability of prescription, this certification demonstrates the rich functionality of Medasys prescription software designed to optimize patient care in accordance with the business and regulatory requirements.
Clamart, 11 September 2015 – Medasys, leading developer and integrator French medical software for healthcare facilities, public and private, in the areas of patient records, production care and technical support centers (biology, imaging, pharmacy), ad type testing by the certification of the software Help Prescription DxCare (Version 7.7.2), coupled to the Vidal Hoptimal database (2015.5.11 release) by SGS ICS agency for its functionality in accordance with the June 2012 repository HAS. The audit revealed that the integrated prescription Medasys engine, meets all the criteria required by the repository for prescription at hospital and ambulatory performance.
Mandatory for all software limitations, since 1 st in January 2015, aims to promote LAP certification has features that improve the quality and safety prescription (eg reporting of cons-indications or allergies), to facilitate the work of the prescribing physician, foster regulatory compliance of the order (eg prescription generic name), and decrease the quality of treatment costs equal.
“The result of a true collaboration with our users referents and with the Vidal Company, this certification is to recognize the efforts of all teams to achieve these goals. The features provided should enable us to a new level in securing the prescription chain and enhance the value of a real-time sharing of medical records data in this process, “explains Frédéric Vaillant, CEO of Medasys. “This system which follows the health professionals in their daily mission, and promotes continuity of care pathways in a logic comply with regulatory requirements. “
According to current international health issues, Medasys is now positioned as an operator of health services aimed, through its innovative solutions trades, putting the patient at the heart of an efficient and secure care system.
About Medasys
Medasys is a leading provider of software solutions in the areas of patient records, production care, biology and medical imaging, allowing public and private health facilities to optimize and reliable medical processes in a patient safety logic, performance and cost control.
Medasys employs 215 employees and is present in France (Lyon and Clamart), as well as Belgium, Algeria, Morocco and Japan. Since November 2011, Medasys is part of the NoemaLife Group Health IT leader, thus constituting one of Europe’s leading providers of software solutions for Health. Listed on the Italian Stock Exchange (MTA) since 2006 (ISIN IT0004014533-NOE), NoemaLife has 450 employees and is present in Italy, Germany, United Kingdom, Argentina, Chile and United Arab Emirates.
Medasys is listed on Compartment C of Eurolist Paris (stock code MED – ISIN code FR 0000052623)
In addition to its business activities, Medasys is also determined to act on its internal operations through an environmental policy that follows four main principles of action: reduce its consumption of water, electricity, waste and control its promote low-impact travel. Medasys is ISO 14001 v2004 since 21 December 2012.
Learn more about Medasys: www.medasys.com
Contact Medasys:
Service Marketing Communication
Phone: +33 (0) 1 75 60 90 91 – Email: servicepresse@medasys.com
mailto: servicepresse@medasys.com
CP LAP certification
http://hugin.info/143499/R/ 1951428 / 709635.pdf
This announcement is distributed by NASDAQ OMX Corporate Solutions is Behalf of NASDAQ OMX Corporate Solutions customers. The
issuer of this announcement warrants That They Are Solely responsible for the content, accuracy and originality of the information contained Therein
. Source: GlobeNewswire via MEDASYS
HUG # 1951428
No comments:
Post a Comment